<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CPJ</journal-id>
<journal-id journal-id-type="hwp">spcpj</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Pediatr (Phila)</journal-id>
<journal-title>Clinical Pediatrics</journal-title>
<issn pub-type="ppub">0009-9228</issn>
<issn pub-type="epub">1938-2707</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0009922812441672</article-id>
<article-id pub-id-type="publisher-id">10.1177_0009922812441672</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sternoclavicular Joint Arthritis as the Initial Presentation of Crohn’s Disease in an Adolescent</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Thomas</surname><given-names>Kathryn S.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0009922812441672">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ray</surname><given-names>Linda I.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0009922812441672">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Giles</surname><given-names>Henry W.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0009922812441672">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Nowicki</surname><given-names>Michael J.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0009922812441672">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0009922812441672"><label>1</label>University of Mississippi Medical Center, Jackson, MS, USA</aff>
<author-notes>
<corresp id="corresp1-0009922812441672">Michael J. Nowicki, Division of Pediatric Gastroenterology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA. Email: <email>mnowicki@umc.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>52</volume>
<issue>8</issue>
<fpage>767</fpage>
<lpage>769</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<sec id="section1-0009922812441672" sec-type="intro">
<title>Introduction</title>
<p>Crohn’s disease (CD) is protean in its presentation, manifesting with symptoms and signs referable to the gastrointestinal tract and/or secondary to extraintestinal involvement. It is estimated that up to 35% of individuals with inflammatory bowel disease (IBD) experience extraintestinal manifestations, which typically involve the musculoskeletal system, skin, eyes, and hepatobiliary system.<sup><xref ref-type="bibr" rid="bibr1-0009922812441672">1</xref></sup> Extraintestinal manifestations may predate intestinal symptoms and signs, causing a delay in the diagnosis of CD. We report an adolescent with sternoclavicular joint (SCJ) arthritis as her initial presentation of CD, 6 months before the onset of gastrointestinal symptoms. We present this case to highlight the importance of recognizing that extraintestinal manifestations may be the presenting symptom in IBD.</p>
</sec>
<sec id="section2-0009922812441672" sec-type="cases">
<title>Case Report</title>
<p>A previously healthy 14-year-old female presented with a 5-month history of sternoclavicular pain and swelling. She had no known trauma to the area. The pain was worse in the evenings, on waking in the morning, and when pressure was applied to the area. At initial evaluation by her primary care provider 3 months prior, she was started on daily ibuprofen; the patient reported some slight improvement. There was no history of peripheral joint swelling or pain, morning stiffness, or rashes. She reported no history of fever, illnesses, trauma, rashes, nodules, bruising, photosensitivity, or hair loss. She did complain of intermittent, nonspecific abdominal pain that occasionally led to nausea and vomiting; there was no history of rectal bleeding, diarrhea, or constipation.</p>
<p>Past medical history was significant for hospitalization as a neonate for late group B strep infection. She was receiving monteleukast for allergic rhinitis. Past surgeries included correction of fifth toe overlay, fusion of the tarsometatarsal joint of the right foot, and removal of a mole from her right arm. She had fractures of both wrists at 4 years of age. Family history was significant for rheumatoid arthritis on the maternal side.</p>
<p>At presentation, the only positive finding on physical examination was a tender nodule at left SCJ.</p>
<p>Laboratory evaluation included a complete blood count, C-reactive protein, antinuclear antibody, rheumatoid factor, serum electrolytes, liver panel, lactate dehydrogenase, and urinalysis. No abnormalities were noted on laboratory studies. The patient was also negative for HLA-B27. An x-ray of the clavicle showed no obvious abnormality. An MRI performed 3 weeks later showed abnormal T2 signal involving the left SCJ consistent with joint effusion (<xref ref-type="fig" rid="fig1-0009922812441672">Figure 1</xref>). There was abnormal contrast enhancement at the left SCJ when compared with the right, consistent with an inflammatory process. The marrow cavity appeared normal without cortical disruption or significant bone marrow edema. The manubrium appeared normal in signal intensity. Treatment with ibuprofen was continued.</p>
<fig id="fig1-0009922812441672" position="float">
<label>Figure 1.</label>
<caption>
<p>Magnetic resonance imaging of the sternoclavicular joint.</p>
<p>Coronal (A) and axial (B) T2-weighted fat-saturated magnetic resonance images demonstrate abnormal bright signal within the left sternoclavicular joint representing abnormal joint fluid and nonspecific inflammation.</p>
</caption>
<graphic xlink:href="10.1177_0009922812441672-fig1.tif"/>
</fig>
<p>One week later, she presented to the emergency department with complaints of nausea, vomiting, hematochezia, vague abdominal pain, and worsening left sternoclavicular pain. The computed tomography scan of the abdomen and pelvis obtained from the emergency department showed ileocecal inflammation. The following day colonoscopy was performed showing significant ulceration and narrowing ileocecal valve; the remainder of the colon was grossly normal in appearance. Pathological findings from the cecum at the ileocecal valve were consistent with ulcer formation; no pathological findings were noted in the rest of the colon. An upper gastrointestinal series with small bowel follow through confirmed terminal ileum involvement; the remainder of the small bowel appeared normal. A diagnosis of CD was rendered and treatment started with prednisone ( 50 mg daily), metronidazole (250 mg thrice a day), asacol (400 mg thrice a day), and ranitidine (150 mg twice a day).</p>
</sec>
<sec id="section3-0009922812441672" sec-type="discussion">
<title>Discussion</title>
<p>We report an adolescent with CD who presented initially with SCJ arthritis, a relatively uncommon site for arthritis. She was treated with nonsteroidal anti-inflammatory drugs (NSAIDs) for 6 months before developing gastrointestinal complaints of abdominal pain and rectal bleeding. Subsequent evaluation confirmed a diagnosis of CD.</p>
<p>It has been estimated that 20% of children with IBD present with arthritis, including peripheral arthritis, spondyloarthritis, ankylosing spondylitis (AS), and sacroiliitis.<sup><xref ref-type="bibr" rid="bibr2-0009922812441672">2</xref></sup> Arthritis is one of the most common extraintestinal manifestations in pediatric IBD accounting for 26% of extraintestinal manifestations prior to diagnosis and 17% of extraintestinal manifestations following diagnosis of IBD.<sup><xref ref-type="bibr" rid="bibr3-0009922812441672">3</xref></sup> Peripheral arthritis occurs more commonly than axial arthritis in children with IBD.<sup><xref ref-type="bibr" rid="bibr3-0009922812441672">3</xref></sup> Prevalence rates for AS in children with IBD are not well established. However, AS is found in 3.4% to 10% of adults with IBD<sup><xref ref-type="bibr" rid="bibr4-0009922812441672">4</xref><xref ref-type="bibr" rid="bibr5-0009922812441672"/>-<xref ref-type="bibr" rid="bibr6-0009922812441672">6</xref></sup> and 6% of adults with CD.<sup><xref ref-type="bibr" rid="bibr6-0009922812441672">6</xref></sup> In a small study, AS preceded IBD symptoms in 75% of patients affected by both.<sup><xref ref-type="bibr" rid="bibr6-0009922812441672">6</xref></sup></p>
<p>In addition to CD, SCJ arthritis may accompany spondyloarthritis, complicate trauma, or occur secondary to septic arthritis. In a review by Taccari et al,<sup><xref ref-type="bibr" rid="bibr7-0009922812441672">7</xref></sup> SCJ arthritis was reported in up to 41% of patients with rheumatoid arthritis, 28% of patients with AS, and 15% of patients with psoriatic arthritis. SCJ involvement has been documented by MRI in up to 20% of adults with AS.<sup><xref ref-type="bibr" rid="bibr8-0009922812441672">8</xref></sup> Septic arthritis of the SCJ is rare, accounting for 0.5% to 1% of all septic arthritis.<sup><xref ref-type="bibr" rid="bibr9-0009922812441672">9</xref></sup> Risk factors for septic arthritis of the SCJ included trauma, intravenous drug injection, and immunocompromised states.<sup><xref ref-type="bibr" rid="bibr10-0009922812441672">10</xref></sup></p>
<p>Initial treatment of arthritis in the patient described herein consisted of NSAIDs. NSAIDs inhibit the production of prostanoids, which are elevated as part of the reparative process in IBD.<sup><xref ref-type="bibr" rid="bibr11-0009922812441672">11</xref>,<xref ref-type="bibr" rid="bibr12-0009922812441672">12</xref></sup> As such, NSAIDs may lead to worsening of gastrointestinal symptoms in patients with IBD. NSAID exposure has been associated with a nearly 2-fold risk for hospital admission for colitis due to IBD.<sup><xref ref-type="bibr" rid="bibr11-0009922812441672">11</xref></sup> Moreover, NSAIDs are associated with frequent and early relapse of quiescent IBD.<sup><xref ref-type="bibr" rid="bibr13-0009922812441672">13</xref></sup> Nonselective NSAIDs pose a greater risk than selective NSAIDs,<sup><xref ref-type="bibr" rid="bibr13-0009922812441672">13</xref></sup> but selective NSAIDs can also cause worsening of IBD.<sup><xref ref-type="bibr" rid="bibr12-0009922812441672">12</xref></sup></p>
<p>In conclusion, this brief report highlights the importance of recognizing that arthritis may represent the initial manifestation of CD. Although first-line treatment for arthritis is NSAIDs, in the present case use of NSAIDs may have exacerbated gastrointestinal symptoms due to their deleterious effect on gut mucosa in IBD.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0009922812441672">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Su</surname><given-names>CG</given-names></name>
<name><surname>Judge</surname><given-names>TA</given-names></name>
<name><surname>Lichenstein</surname><given-names>GR</given-names></name>
</person-group>. <article-title>Extraintestinal manifestations of inflammatory bowel disease</article-title>. <source>Gastroenterol Clin North Am</source>. <year>2002</year>;<volume>31</volume>:<fpage>307</fpage>-<lpage>327</lpage>.</citation>
</ref>
<ref id="bibr2-0009922812441672">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jacques</surname><given-names>P</given-names></name>
<name><surname>Mielants</surname><given-names>H</given-names></name>
<name><surname>Coppieters</surname><given-names>K</given-names></name>
<name><surname>De Vos</surname><given-names>M</given-names></name>
<name><surname>Elewaut</surname><given-names>D</given-names></name>
</person-group>. <article-title>The intimate relationship between gut and joint in spondyloarthropathies</article-title>. <source>Curr Opin Rheumatol</source>. <year>2007</year>;<volume>19</volume>:<fpage>353</fpage>-<lpage>357</lpage>.</citation>
</ref>
<ref id="bibr3-0009922812441672">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jose</surname><given-names>FA</given-names></name>
<name><surname>Garnett</surname><given-names>EA</given-names></name>
<name><surname>Vittinghoff</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease</article-title>. <source>Inflamm Bowel Dis</source>. <year>2009</year>;<volume>15</volume>:<fpage>63</fpage>-<lpage>68</lpage>.</citation>
</ref>
<ref id="bibr4-0009922812441672">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dekker-Saeys</surname><given-names>BJ</given-names></name>
<name><surname>Meuwissen</surname><given-names>SG</given-names></name>
<name><surname>Van Den Berg-Loonen</surname><given-names>EM</given-names></name>
<etal/>
</person-group>. <article-title>Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease</article-title>. <source>Ann Rheum Dis</source>. <year>1978</year>;<volume>37</volume>:<fpage>33</fpage>-<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr5-0009922812441672">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Vlam</surname><given-names>K</given-names></name>
<name><surname>Mielants</surname><given-names>H</given-names></name>
<name><surname>Cuvelier</surname><given-names>C</given-names></name>
<name><surname>De Keyser</surname><given-names>F</given-names></name>
<name><surname>Veys</surname><given-names>EM</given-names></name>
<name><surname>De Vos</surname><given-names>M</given-names></name>
</person-group>. <article-title>Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association</article-title>. <source>J Rheumatol</source>. <year>2000</year>;<volume>27</volume>:<fpage>2860</fpage>-<lpage>2865</lpage>.</citation>
</ref>
<ref id="bibr6-0009922812441672">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Palm</surname><given-names>O</given-names></name>
<name><surname>Moum</surname><given-names>B</given-names></name>
<name><surname>Ongre</surname><given-names>A</given-names></name>
<name><surname>Gran</surname><given-names>JT</given-names></name>
</person-group>. <article-title>Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study)</article-title>. <source>J Rheumatol</source>. <year>2002</year>;<volume>29</volume>:<fpage>511</fpage>-<lpage>515</lpage>.</citation>
</ref>
<ref id="bibr7-0009922812441672">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Taccari</surname><given-names>E</given-names></name>
<name><surname>Spadaro</surname><given-names>A</given-names></name>
<name><surname>Riccieri</surname><given-names>V</given-names></name>
<name><surname>Guerrisi</surname><given-names>R</given-names></name>
<name><surname>Guerrisi</surname><given-names>V</given-names></name>
<name><surname>Zoppini</surname><given-names>A</given-names></name>
</person-group>. <article-title>Sternoclavicular joint disease in psoriatic arthritis</article-title>. <source>Ann Rheum Dis</source>. <year>1992</year>;<volume>51</volume>:<fpage>372</fpage>-<lpage>374</lpage>.</citation>
</ref>
<ref id="bibr8-0009922812441672">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weber</surname><given-names>U</given-names></name>
<name><surname>Pfirrmann</surname><given-names>CW</given-names></name>
<name><surname>Kissling</surname><given-names>RO</given-names></name>
<name><surname>Hodler</surname><given-names>J</given-names></name>
<name><surname>Zanetti</surname><given-names>M</given-names></name>
</person-group>. <article-title>Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis</article-title>. <source>BMC Musculoskelet Disord</source>. <year>2007</year>;<volume>8</volume>:<fpage>20</fpage>-<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr9-0009922812441672">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ross</surname><given-names>JJ</given-names></name>
<name><surname>Shamsuddin</surname><given-names>H</given-names></name>
</person-group>. <article-title>Sternoclavicular septic arthritis: review of 180 cases</article-title>. <source>Medicine (Baltimore)</source>. <year>2004</year>;<volume>83</volume>:<fpage>139</fpage>-<lpage>148</lpage>.</citation>
</ref>
<ref id="bibr10-0009922812441672">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>WS</given-names></name>
<name><surname>Wan</surname><given-names>YL</given-names></name>
<name><surname>Lui</surname><given-names>CC</given-names></name>
<name><surname>Lee</surname><given-names>TY</given-names></name>
<name><surname>Wang</surname><given-names>KC</given-names></name>
</person-group>. <article-title>Extrapleural abscess secondary to infection of the sternoclavicular joint. Report of two cases</article-title>. <source>J Bone Joint Surg Am</source>. <year>1993</year>;<volume>75</volume>:<fpage>1835</fpage>-<lpage>1839</lpage>.</citation>
</ref>
<ref id="bibr11-0009922812441672">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Evans</surname><given-names>JM</given-names></name>
<name><surname>McMahon</surname><given-names>AD</given-names></name>
<name><surname>Murray</surname><given-names>FE</given-names></name>
<name><surname>McDevitt</surname><given-names>DG</given-names></name>
<name><surname>MacDonald</surname><given-names>TM</given-names></name>
</person-group>. <article-title>Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease</article-title>. <source>Gut</source>. <year>1997</year>;<volume>40</volume>:<fpage>619</fpage>-<lpage>622</lpage>.</citation>
</ref>
<ref id="bibr12-0009922812441672">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McCartney</surname><given-names>SA</given-names></name>
<name><surname>Mitchell</surname><given-names>JA</given-names></name>
<name><surname>Fairclough</surname><given-names>PD</given-names></name>
<name><surname>Farthing</surname><given-names>MJ</given-names></name>
<name><surname>Warner</surname><given-names>TD</given-names></name>
</person-group>. <article-title>Selective COX-2 inhibitors and human inflammatory bowel disease</article-title>. <source>Aliment Pharmacol Ther</source>. <year>1999</year>;<volume>13</volume>:<fpage>1115</fpage>-<lpage>1117</lpage>.</citation>
</ref>
<ref id="bibr13-0009922812441672">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Takeuchi</surname><given-names>K</given-names></name>
<name><surname>Smale</surname><given-names>S</given-names></name>
<name><surname>Premchand</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease</article-title>. <source>Clin Gastroenterol Hepatol</source>. <year>2006</year>;<volume>4</volume>:<fpage>196</fpage>-<lpage>202</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>